A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier surveyed hospitals, health systems and other providers to identify which waivers and flexibilities they are still leveraging and the readiness of providers to unwind...
Premier submitted comments to the Patent and Trade Office and FDA on ways to ensure the patent system does not lead to increased pharmaceutical costs.
Medicare ACOs have proven to be successful platforms for healthcare providers to achieve savings and improve quality of care.
Watch this on-demand webinar to hear from Premier staff as they discuss the various new requirements and policies for providers, as well as what trends...
Dr. Hamed Abbaszadegan shares ways payers and providers can align financial incentives, enhance patient outcomes and forecast the path to VBC delivery.
Premier applauds FDA for addressing the inequities that exists for individuals who identify as LGBTQ+ and their eligibility to donate blood.
Premier provides input on the Administration's proposal to modernize the 40-year-old law governing providers' access to their patients' data on substance use.
The analysis highlights the existing inequities in OUD and points to broader systemic factors that disproportionately affect communities.
New PINC AI™ data shows that the prevalence of opioid use disorder (OUD) is not evenly distributed across states.
OUD patients average 32.5 percent higher cost per ED visit and 8 percent higher cost per inpatient visit than those without an OUD diagnosis.
As the 118th Congress commences, government leaders have an opportunity to coalesce around meaningful healthcare policy solutions.
Premier is committed to helping reduce supply and inflation risks across at-risk categories to build a stronger healthcare supply chain for the future.